Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ocugen, Inc. Director's Dealing 2024

Jul 2, 2024

32915_dirs_2024-07-02_bbde3c07-e4f9-4339-ad19-7678253311a6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2024-06-28

Reporting Person: Zhang Junge (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-28 Option (Right to Buy) $1.55 A 66929 Acquired 2034-06-28 Common Stock (66929) Direct

Footnotes

F1: The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.